Press "Enter" to skip to content

New patent expiration for Abbvie drug TRICOR

3
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie drug TRICOR

Annual Drug Patent Expirations for TRICOR
Annual Drug Patent Expirations for TRICOR

Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. It is available from five suppliers. There are three patents protecting this drug and two Paragraph IV challenges.

TRICOR drug price trends.

Drug patent litigation for TRICOR.

This drug has one hundred and fifty-five patent family members in twenty-seven countries.

The generic ingredient in TRICOR is fenofibrate. Five suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie drug TRICOR

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!